期刊文献+

从阿尔茨海默病新诊断指南看轻度认知功能损害概念的变化 被引量:1

Change of mild cognitive impairment concept: understanding from the new diagnostic guidelines for Alzheimer's disease
下载PDF
导出
摘要 阿尔茨海默病(AD)是以认知功能损害为突出表现的神经系统退变性疾病。轻度认知功能障碍(MCI)是认知功能低于同龄及文化背景的正常人但未达到痴呆程度的认知功能损害状态,被认为是痴呆、特别是AD的危险因素。临床及流行病学的研究表明MCI存在着异质性,有关MCI的概念及转归一直存在争论。随着对AD痴呆前阶段的关注,有必要了解MCI的含义及其变化。本文复习了MCI概念的提出、定义及其内容上发生的变化,并介绍了新的NIA—AD工作组AD诊断指南。 Alzheimer's disease (AD) is a neurodegenerative illness characterized by a profound impairment of cognitive function. Mild cognitive impairment (MCI) is characterized by a less severe level of cognitive impairment but with no dementia. MCI has been presumed to be a high-risk for developing dementia, especially AD. Actually, there have been disputes on definition and clinical outcome of MCI. Heterogeneity in the term MCI was demonstrated by both clinical and epidemiological researches. As the "pre-dementia" phase of AD draws more and more attention from researchers, it is essential to understand the changes in definition of MCI. This paper reviewed the changes in concept of MCI, and introduced the new diagnostic criteria of AD proposed by the National Institute (U.S.) Aging-Alzheimer's disease workgroup.
作者 张新卿
出处 《中华老年多器官疾病杂志》 2012年第4期241-243,共3页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 阿尔茨海默病 轻度认知功能损害 诊断 Alzheimer's disease mild cognitive impairment diagnosis
  • 相关文献

参考文献6

  • 1Mckhann GM., Knopman DS, diagnosis of dementia due recommendations from the Aging-Alzheimer's Association Chertkow H, et al. The to Alzheimer's disease: National Institute on workgroups on diagnostic guidelines for Alzheimer's disease[J]. Alzheimer Dement, 2011 (7): 263-269.
  • 2Albert MS, Dekosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease[J]. Alzheimer Dement, 2011 (7): 270-279.
  • 3Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease[J]. Alzheimer Dement, 2011(7): 280-292.
  • 4Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies[J]. Acta Psychiatr Scand, 2009(119): 252-265.
  • 5Petersen RC, Stevens JC, Ganguli M, et al. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology[J]. Neurology, 2001(56): 1133-1142.
  • 6Petersen RC, Negash S. Mild cognitive impairment: an overview[J]. CNS Spectr, 2008(13): 45-53.

同被引文献25

  • 1Sperling RA,Aisen PS,Beckett LA. Toward defining the reclini-cal stages of Alzheimer,s disease:recommendations from the National Institute on Aging-Alzheimer′s Association workgroups on diagnostic guidelines for Alzheimer′s disease[J].Alzheimer Dement,2011.280-292.
  • 2Albert MS,Dekosky ST,Dickson D. The diagnosis of mild cogni-tive impairment due to Alzheimer′s disease:recommendations from the National Institute on Aging-Alzheimer Association workgroups on diag-nostic guidelines for Alzheime′s rdisease[J].Alzheimers Dement,2011.270-279.
  • 3Mckhann GM,Knopman DS,Chertkow H. The diagnosis of de-mentia due to Alzheimer disease:recommendations from the National Institute on Aging-Alzheimer′s Association workgroups on diagnostic guidelines for Alzheimer′s[J].Alzheimers Dement,2011.263-269.
  • 4Albert M,Blacker D,Moss MB. Longitudinal change incognitive performance among individuals with mild cognitiveimpairment[J].Neuro-psychology,2007.158-169.
  • 5Drago V,Babiloni C,Bartrés-Faz D. Disease trackingmarkers for Alzheimer′s disease at the prodromal(MCI)stage[J].{H}Journal of Alzheimer's Disease,2011,(Suppl 3):159-199.
  • 6Vos S,van Rossum I,Burns L. Test sequenceof CSF and MRI biomark-ers for prediction Test sequenceof CSF and MRI biomarkers for predic-tion[J].{H}NEUROBIOLOGY OF AGING,2012.2272-2281.
  • 7Gertz HJ,Kurz A. Diagnosis without therapy:early diagnosis of Alzhei-mer′s disease in the stage of mildcognitive impairment[J].{H}NERVENARZT,2011.1151-1159.
  • 8Blasko I,Jellinger K,Kemmler G. Conversion from cognitive health to mild cognitive impairment and Alzheimer′s disease:predic-tion by plasma amyloid beta 42,medial temporal lobe atrophy and ho-mocysteine[J].{H}NEUROBIOLOGY OF AGING,2008.1-11.
  • 9Philipp A,Thomann MD,Elmar Kaiser MD. Association of total tau and phosphorylated tau 181 protein levels in cerebrospinal fluid with cerebral atrophy in mild cognitive impairment and Alzheimer dis-ease[J].Rev Psychiatr Neurosci,2009.34.
  • 10Parnetti L,Chiasserini D,Eusebi P. Performance of A β1-40,A β1-42,TotalTau,and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment[J].{H}Journal of Alzheimer's Disease,2012.229-238.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部